bioMerieux S.A. Market Share Analysis

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

bioMerieux S.A. Market Share Analysis
Published on November 2009

Report Summary


Summary

This report is an essential source for data, analysis and strategic insight into the medical equipment business of bioMerieux S.A.. The
report provides key information relating to bioMerieux S.A. medical equipment revenue, market share by sector and country, financial
and SWOT analysis of the company. The report examines the medical equipment business structure and operations, history and
products, and provides an analysis of its key medical equipment revenue lines. It inspects the company's strategic strengths and
weaknesses.

Scope

- Revenues for the medical equipment markets and sub-sectors by country and region.
- Provides the share of market and sub sectors by country and region.
- Detailed breakdown revenues contributed by the medical equipment business operations.
- Provides summary of the medical equipment pipeline products that the company is developing.
- Critical analysis of the company's strengths, weaknesses opportunities and threats.
- Provides summary analysis of key revenue lines and strategy.
- Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and
services and the latest available company statement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
- Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

- A single source to fulfill all of your business and competitor intelligence needs
- Research your competitor's business structure, strategy and prospects.
- Counter your competitor's strengths and target their weaknesses.
- Identify your competitor's key revenue streams by market and geography.
- Identify and assess potential corporate and investment opportunities.
- Support sales activities by understanding your customers businesses better.
- Identify potential competitor products before they reach market.
- Qualify prospective partners and suppliers.

Table of Content

1 Table of Contents
1 Table Of Contents 2

bioMerieux S.A. Market Share Analysis Page 1/9


1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About' 11
3 Definitions of Markets/Categories Covered 12
3.1 In Vitro Diagnostics 12
3.1.1 Genetic Testing 12
3.1.2 Immuno Chemistry 12
3.1.3 Infectious Immunology 12
3.1.4 Microbiology Culture 12
4 Company Snapshot 13
4.1 Key Information 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13
5 Business Description 14
5.1 Business Overview 14
5.2 Clinical Applications 14
5.2.1 Overview 14
5.2.2 Financials 15
5.2.3 Key Strategies 15
5.3 Industrial Applications 15
5.3.1 Overview 15
5.3.2 Financials 15
5.3.3 Key Strategies 15
5.4 Major Products and Services 16
5.4.1 Overview 16
6 History 18
7 Business Strategy 20
7.1 Mission Statement 20
7.2 Corporate Social Responsibility 20
7.2.1 Overview 20
7.2.2 Specific CSR Initiatives 20
8 SWOT Analysis 21
8.1 Overview 21
8.2 bioMerieux S.A. Strengths 22
8.2.1 Expanding Operating Margin 22
8.2.2 Efficient Use of Resources 22
8.2.3 Global Presence 22
8.2.4 Business Development Agreements 22
8.2.5 Strong Research and Development Activities 23
8.3 bioMerieux S.A. Weaknesses 23
8.3.1 Limited Liquidity Position 23
8.3.2 Flat Sales Growth in North America 23
8.3.3 Closure of Boxtel Site 23
8.4 bioMerieux S.A. Opportunities 23
8.4.1 Market Growth in Emerging Economies 23
8.4.2 New Subsidiaries 24
8.4.3 Joint Venture 24
8.4.4 Strategic Acquisitions 24



8.5 bioMerieux S.A. Threats 24
8.5.1 Disputes 24
8.5.2 Introduction of Innovative Technologies 25
8.5.3 Industry Consolidation Challenges 25
9 Competitors 26
10 bioMerieux S.A. Medical Equipment Market Share Analysis 27
10.1 bioMerieux S.A., In Vitro Diagnostics, Global, Market Share (2008) 27
10.2 bioMerieux S.A., APAC, Market Share (2008) 28
10.3 bioMerieux S.A., Europe, Market Share (2008) 29
10.4 bioMerieux S.A., MEA, Market Share (2008) 30
10.5 bioMerieux S.A., North America, Market Share (2008) 31
10.6 bioMerieux S.A., SCA, Market Share (2008) 32
11 bioMerieux S.A. Medical Equipment Market Share Analysis by Category 33
11.1 bioMerieux S.A., In Vitro Diagnostics, Global, Category Revenue Share (2008) 33
11.2 bioMerieux S.A., APAC, Category Revenue Share (2008) 35
11.2.1 bioMerieux S.A., Australia, Category Revenue Share (2008) 37
11.2.2 bioMerieux S.A., China, Category Revenue Share (2008) 39
11.2.3 bioMerieux S.A., India, Category Revenue Share (2008) 41
11.2.4 bioMerieux S.A., Japan, Category Revenue Share (2008) 43
11.2.5 bioMerieux S.A., Others, Category Revenue Share (2008) 45
11.3 bioMerieux S.A., Europe, Category Revenue Share (2008) 47
11.3.1 bioMerieux S.A., France, Category Revenue Share (2008) 49
11.3.2 bioMerieux S.A., Germany, Category Revenue Share (2008) 51
11.3.3 bioMerieux S.A., Italy, Category Revenue Share (2008) 53
11.3.4 bioMerieux S.A., Spain, Category Revenue Share (2008) 55
11.3.5 bioMerieux S.A., United Kingdom, Category Revenue Share (2008) 57
11.4 bioMerieux S.A., MEA, Category Revenue Share (2008) 61
11.5 bioMerieux S.A., North America, Category Revenue Share (2008) 63
11.5.1 bioMerieux S.A., Canada, Category Revenue Share (2008) 65
11.5.2 bioMerieux S.A., United States, Category Revenue Share (2008) 67
11.6 bioMerieux S.A., SCA, Category Revenue Share (2008) 69
11.6.1 bioMerieux S.A., Brazil, Category Revenue Share (2008) 71
12 Key Employees 75
13 Key Employee Biographies 76
14 Company Statement 77
15 Locations And Subsidiaries 78
15.1 Head Office 78
15.2 Other Locations & Subsidiaries 78
16 bioMerieux S.A. Detailed Deal Summary 80
16.1 Venture Financing 80
16.1.1 AdvanDx Secures $15 Million Series C Financing 80
16.2 Partnerships 81
16.2.1 bioMerieux Enters Into Licensing Agreement With ProteoSys 81
16.2.2 bioMerieux Enters Into Licensing Agreement With DiagnoSwiss 82
16.2.3 bioMerieux Enters Into An Agreement With NuGEN Technologies 83
16.2.4 Biomerieux Signs A Licensing Agreement With Labtech Systems 84
16.2.5 bioMerieux Enters Into Licensing Agreement With NorChip 85
16.2.6 Abaxis Enters Into Licensing Agreement With bioMerieux 86



16.2.7 bioTheranostics Signs An Agreement With Lab21 87
16.2.8 bioMerieux Enters Into Research Agreement With Foundation for Innovative New Diagnostics 88
16.2.9 bioMerieux Enters Into An Agreement With Hitachi High-Technologies 89
16.2.10 bioMerieux Enters Into An Agreement With Wescor 90
16.2.11 bioMerieux Forms Joint Venture With Shanghai Kehua Bio-engineering 91
16.2.12 Sysmex Forms Joint Venture With bioMerieux 92
16.3 Equity Offering 93
16.3.1 Labtech Systems Completes Private Placement Of $1.79 Million With Biomerieux 93
16.4 Acquisition 94
16.4.1 bioMerieux Acquires PML Microbiologicals From Pelican Life Sciences 94
16.4.2 bioMerieux Acquires AviaraDx 95
16.4.3 bioMerieux Acquires AB BIODISK 96
16.4.4 bioMerieux Acquires BTF From Kestrel Capital 97
16.4.5 Biomerieux Acquires Biomedics 98
17 Recent Developments 99
17.1 Strategy And Business Planning 99
17.1.1 Apr 03, 2008: bioMérieux, University of Sunderland Collaborate In New Research To Improve The Identification Of
Pseudomonas aeruginosa 99
17.1.2 Mar 17, 2008: BioMerieux Enters Into Strategic Partnership With Hitachi 99
17.1.3 Jan 08, 2008: BioMerieux Transfers Certain R&D And Manufacturing Activities To France 100
17.1.4 Dec 13, 2007: BioMerieux Opens South African Subsidiary 100
17.2 Financial Announcements 100
17.2.1 Sep 07, 2009: bioMerieux Reports Net Income Of EUR63.4 Million In H1 2009 100
17.2.2 Sep 07, 2009: BioMerieux Raises Margin Target With Increase Of H1 103
17.2.3 Apr 23, 2009: bioMerieux Posts Net Sales Of EUR166.9 Million For Q1 2009 103
17.2.4 Mar 16, 2009: bioMerieux Reports 2008 Results 105
17.2.5 Jan 20, 2009: bioMerieux Reports Preliminary 2008 Results 106
17.3 Research And Development 108
17.3.1 Apr 03, 2008: bioMérieux, University of Sunderland Collaborate In New Research To Improve The Identification Of
Pseudomonas aeruginosa 108
17.4 Legal and Regulatory 109
17.4.1 May 15, 2008: bioMerieux And FIND Signs MOU 109
17.5 Other Significant Developments 109
17.5.1 Mar 06, 2008: bioMerieux Opens New Subsidiary In Singapore 109
18 Appendix 110
18.1 Research Methodology 111
18.2 Secondary Research 112
18.3 Primary Research 112
18.4 Models 113
18.5 Forecasts 113
18.6 Expert Panels 113
18.7 GlobalData Consulting 114
18.8 Contact Us 114
18.9 Disclaimer 114
1.1 List of Tables

Table 1: bioMerieux S.A., Key Facts, 2009 13
Table 2: bioMerieux S.A., SWOT Analysis, 2008 21
Table 3: bioMerieux S.A., In Vitro Diagnostics, Global, Revenue ($ mn) and Market Share (%), 2008 27



Table 4: bioMerieux S.A., In Vitro Diagnostics, APAC, Revenue ($ mn) and Market Share (%), 2008 28
Table 5: bioMerieux S.A., In Vitro Diagnostics, Europe, Revenue ($ mn) and Market Share (%), 2008 29
Table 6: bioMerieux S.A., In Vitro Diagnostics, MEA, Revenue ($ mn) and Market Share (%), 2008 30
Table 7: bioMerieux S.A., In Vitro Diagnostics, North America, Revenue ($ mn) and Market Share (%), 2008 31
Table 8: bioMerieux S.A., In Vitro Diagnostics, SCA, Revenue ($ mn) and Market Share (%), 2008 32
Table 9: bioMerieux S.A., In Vitro Diagnostics, Global, Revenue ($ mn) and Market Share (%) by Category, 2008 34
Table 10: bioMerieux S.A., In Vitro Diagnostics, APAC, Revenue ($ mn) and Market Share (%) by Category, 2008 36
Table 11: bioMerieux S.A., In Vitro Diagnostics, Australia, Revenue ($ mn) and Market Share (%) by Category, 2008 38
Table 12: bioMerieux S.A., In Vitro Diagnostics, China, Revenue ($ mn) and Market Share (%) by Category, 2008 40
Table 13: bioMerieux S.A., In Vitro Diagnostics, India, Revenue ($ mn) and Market Share (%) by Category, 2008 42
Table 14: bioMerieux S.A., In Vitro Diagnostics, Japan, Revenue ($ mn) and Market Share (%) by Category, 2008 44
Table 15: bioMerieux S.A., In Vitro Diagnostics, Others, Revenue ($ mn) and Market Share (%) by Category, 2008 46
Table 16: bioMerieux S.A., In Vitro Diagnostics, Europe, Revenue ($ mn) and Market Share (%) by Category, 2008 48
Table 17: bioMerieux S.A., In Vitro Diagnostics, France, Revenue ($ mn) and Market Share (%) by Category, 2008 50
Table 18: bioMerieux S.A., In Vitro Diagnostics, Germany, Revenue ($ mn) and Market Share (%) by Category, 2008 52
Table 19: bioMerieux S.A., In Vitro Diagnostics, Italy, Revenue ($ mn) and Market Share (%) by Category, 2008 54
Table 20: bioMerieux S.A., In Vitro Diagnostics, Spain, Revenue ($ mn) and Market Share (%) by Category, 2008 56
Table 21: bioMerieux S.A., In Vitro Diagnostics, United Kingdom, Revenue ($ mn) and Market Share (%) by Category, 2008 58
Table 23: bioMerieux S.A., In Vitro Diagnostics, MEA, Revenue ($ mn) and Market Share (%) by Category, 2008 62
Table 24: bioMerieux S.A., In Vitro Diagnostics, North America, Revenue ($ mn) and Market Share (%) by Category, 2008 64
Table 25: bioMerieux S.A., In Vitro Diagnostics, Canada, Revenue ($ mn) and Market Share (%) by Category, 2008 66
Table 26: bioMerieux S.A., In Vitro Diagnostics, United States, Revenue ($ mn) and Market Share (%) by Category, 2008 68
Table 27: bioMerieux S.A., In Vitro Diagnostics, SCA, Revenue ($ mn) and Market Share (%) by Category, 2008 70
Table 28: bioMerieux S.A., In Vitro Diagnostics, Brazil, Revenue ($ mn) and Market Share (%) by Category, 2008 72
Table 30: bioMerieux S.A., Key Employees 75
Table 31: bioMerieux S.A., Subsidiaries 78
Table 32: AdvanDx Secures $15 Million Series C Financing 80
Table 33: bioMerieux Enters Into Licensing Agreement With ProteoSys 81
Table 34: bioMerieux Enters Into Licensing Agreement With DiagnoSwiss 82
Table 35: bioMerieux Enters Into An Agreement With NuGEN Technologies 83
Table 36: Biomerieux Signs A Licensing Agreement With Labtech Systems 84
Table 37: bioMerieux Enters Into Licensing Agreement With NorChip 85
Table 38: Abaxis Enters Into Licensing Agreement With bioMerieux 86
Table 39: bioTheranostics Signs An Agreement With Lab21 87
Table 40: bioMerieux Enters Into Research Agreement With Foundation for Innovative New Diagnostics 88
Table 41: bioMerieux Enters Into An Agreement With Hitachi High-Technologies 89
Table 42: bioMerieux Enters Into An Agreement With Wescor 90
Table 43: bioMerieux Forms Joint Venture With Shanghai Kehua Bio-engineering 91
Table 44: Sysmex Forms Joint Venture With bioMerieux 92
Table 45: Labtech Systems Completes Private Placement Of $1.79 Million With Biomerieux 93
Table 46: bioMerieux Acquires PML Microbiologicals From Pelican Life Sciences 94
Table 47: bioMerieux Acquires AviaraDx 95
Table 48: bioMerieux Acquires AB BIODISK 96
Table 49: bioMerieux Acquires BTF From Kestrel Capital 97
Table 50: Biomerieux Acquires Biomedics 98
1.2 List of Figures



Figure 1: bioMerieux S.A., In Vitro Diagnostics, Global, Market Share (%), 2008 27
Figure 2: bioMerieux S.A., In Vitro Diagnostics, APAC, Market Share (%), 2008 28
Figure 3: bioMerieux S.A., In Vitro Diagnostics, Europe, Market Share (%), 2008 29
Figure 4: bioMerieux S.A., In Vitro Diagnostics, MEA, Market Share (%), 2008 30
Figure 5: bioMerieux S.A., In Vitro Diagnostics, North America, Market Share (%), 2008 31
Figure 6: bioMerieux S.A., In Vitro Diagnostics, SCA, Market Share (%), 2008 32
Figure 7: bioMerieux S.A., In Vitro Diagnostics, Global, Category Revenue Share (%), 2008 33
Figure 8: bioMerieux S.A., In Vitro Diagnostics, Global, Market Share (%) by Category, 2008 34
Figure 9: bioMerieux S.A., In Vitro Diagnostics, APAC, Category Revenue Share (%), 2008 35
Figure 10: bioMerieux S.A., In Vitro Diagnostics, APAC, Market Share (%) by Category, 2008 36
Figure 11: bioMerieux S.A., In Vitro Diagnostics, Australia, Category Revenue Share (%), 2008 37
Figure 12: bioMerieux S.A., In Vitro Diagnostics, Australia, Market Share (%) by Category, 2008 38
Figure 13: bioMerieux S.A., In Vitro Diagnostics, China, Category Revenue Share (%), 2008 39
Figure 14: bioMerieux S.A., In Vitro Diagnostics, China, Market Share (%) by Category, 2008 40
Figure 15: bioMerieux S.A., In Vitro Diagnostics, India, Category Revenue Share (%), 2008 41
Figure 16: bioMerieux S.A., In Vitro Diagnostics, India, Market Share (%) by Category, 2008 42
Figure 17: bioMerieux S.A., In Vitro Diagnostics, Japan, Category Revenue Share (%), 2008 43
Figure 18: bioMerieux S.A., In Vitro Diagnostics, Japan, Market Share (%) by Category, 2008 44
Figure 19: bioMerieux S.A., In Vitro Diagnostics, Others, Category Revenue Share (%), 2008 45
Figure 20: bioMerieux S.A., In Vitro Diagnostics, Others, Market Share (%) by Category, 2008 46
Figure 21: bioMerieux S.A., In Vitro Diagnostics, Europe, Category Revenue Share (%), 2008 47
Figure 22: bioMerieux S.A., In Vitro Diagnostics, Europe, Market Share (%) by Category, 2008 48
Figure 23: bioMerieux S.A., In Vitro Diagnostics, France, Category Revenue Share (%), 2008 49
Figure 24: bioMerieux S.A., In Vitro Diagnostics, France, Market Share (%) by Category, 2008 50
Figure 25: bioMerieux S.A., In Vitro Diagnostics, Germany, Category Revenue Share (%), 2008 51
Figure 26: bioMerieux S.A., In Vitro Diagnostics, Germany, Market Share (%) by Category, 2008 52
Figure 27: bioMerieux S.A., In Vitro Diagnostics, Italy, Category Revenue Share (%), 2008 53
Figure 28: bioMerieux S.A., In Vitro Diagnostics, Italy, Market Share (%) by Category, 2008 54
Figure 29: bioMerieux S.A., In Vitro Diagnostics, Spain, Category Revenue Share (%), 2008 55
Figure 30: bioMerieux S.A., In Vitro Diagnostics, Spain, Market Share (%) by Category, 2008 56
Figure 31: bioMerieux S.A., In Vitro Diagnostics, United Kingdom, Category Revenue Share (%), 2008 57
Figure 32: bioMerieux S.A., In Vitro Diagnostics, United Kingdom, Market Share (%) by Category, 2008 58
Figure 35: bioMerieux S.A., In Vitro Diagnostics, MEA, Category Revenue Share (%), 2008 61
Figure 36: bioMerieux S.A., In Vitro Diagnostics, MEA, Market Share (%) by Category, 2008 62
Figure 37: bioMerieux S.A., In Vitro Diagnostics, North America, Category Revenue Share (%), 2008 63
Figure 38: bioMerieux S.A., In Vitro Diagnostics, North America, Market Share (%) by Category, 2008 64
Figure 39: bioMerieux S.A., In Vitro Diagnostics, Canada, Category Revenue Share (%), 2008 65
Figure 40: bioMerieux S.A., In Vitro Diagnostics, Canada, Market Share (%) by Category, 2008 66
Figure 41: bioMerieux S.A., In Vitro Diagnostics, United States, Category Revenue Share (%), 2008 67
Figure 42: bioMerieux S.A., In Vitro Diagnostics, United States, Market Share (%) by Category, 2008 68
Figure 43: bioMerieux S.A., In Vitro Diagnostics, SCA, Category Revenue Share (%), 2008 69
Figure 44: bioMerieux S.A., In Vitro Diagnostics, SCA, Market Share (%) by Category, 2008 70
Figure 45: bioMerieux S.A., In Vitro Diagnostics, Brazil, Category Revenue Share (%), 2008 71
Figure 46: bioMerieux S.A., In Vitro Diagnostics, Brazil, Market Share (%) by Category, 2008 72
Figure 49: GlobalData Methodology 111
Companies mentioned



The following companies are the major competitors of bioMerieux S.A.:
Abbott Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
Biomerieux Sa
Bio-Rad Laboratories, Inc.
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Gen-Probe Incorporated
Hologic, Inc.
Inverness Medical Innovations, Inc.
Ortho-Clinical Diagnostics Inc.
Phadia AB
Qiagen N.V.
Siemens Medical Solutions
Ventana Medical Systems, Inc.



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 1 000.00 Quantity: _____

Site License--USD 2 000.00 Quantity: _____

Corporate License--USD 3 000.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


bioMerieux S.A. Market Share Analysis

Recommended

Recommended

More Related Content

More from ReportLinker.com

More from ReportLinker.com (20)

Recently uploaded

Recently uploaded (20)

bioMerieux S.A. Market Share Analysis